Wednesday, July 1, 2026

Marketing Authorisation Holder (MAHs)

April 17, 2023

NAFDAC approves R21 vaccine for malaria treatment

According to Ms Adeyeye, the R21 malaria vaccine is an adjuvanted protein vaccine presented as a sterile solution.

NAFDAC and R21 malaria vaccine